Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
about
Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 VaccinationThe bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic reviewEfficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumoniaGenome analysis of Legionella pneumophila strains using a mixed-genome microarrayRetrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain).How to approach and treat viral infections in ICU patientsIntravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study.Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in NorwayInternational pneumococcal clones match or exceed the fitness of other strains despite the accumulation of antibiotic resistance.Clinical and Microbiological Factors Associated with High Nasopharyngeal Pneumococcal Density in Patients with Pneumococcal Pneumonia.Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults.Clinical data analysis of 19 cases of community-acquired adenovirus pneumonia in immunocompetent adultsCefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.Role of Atypical Pathogens and the Antibiotic Prescription Pattern in Acute Bronchitis: A Multicenter Study in Korea.Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH.Increasing hospital admissions for pneumonia, EnglandSafety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.Comparison of sputum and nasopharyngeal aspirate samples and of the PCR gene targets lytA and Spn9802 for quantitative PCR for rapid detection of pneumococcal pneumoniaAre third-generation cephalosporins unavoidable for empirical therapy of community-acquired pneumonia in adult patients who require ICU admission? A retrospective studyCumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapySporadic community-acquired Legionnaires' disease in France: a 2-year national matched case-control study.Epidemiology, microbiology and treatment implications in adult patients hospitalized with pneumonia in different regions of China: a retrospective study.Alcohol and the risk of pneumonia: a systematic review and meta-analysis
P2860
Q24658576-650F4C55-A98A-48E7-93E8-01222D568760Q26739685-37AB9808-2181-4E09-AC20-60CBAF26F6EBQ27011229-333FDD63-8225-4706-A3F9-114049A0EA53Q33501357-99777B68-6BEC-4CD6-805B-B3BA7628C972Q33752549-E830B4F1-CCB0-427F-A737-466EFF3E4B2EQ34151093-D1CBE66C-698D-403D-8D4E-89053B0CFD77Q34456313-445AB4B5-42EE-40C3-929D-546CE0D979DAQ34462908-CEF9F55D-5981-40B4-B72C-02255EA0B607Q34894660-B9893A80-C598-4DFE-AED0-EC81D30FE60CQ35024966-6F5CD4E9-7EC3-4233-B003-3EAB767B085DQ35102442-2AEB5628-5B96-4387-A216-5838C86B09A2Q35270677-ACD4402C-7B96-4F38-9E4E-883387E6E9C1Q35806621-950E4593-28F3-41B0-A831-2FA3E89E9E20Q35887032-93DE3711-9069-4E2F-862C-5787F71FEBBBQ35894907-DA97B6F4-A2D5-4268-BB37-A338940940E3Q35966554-BB4A5791-EF1B-4236-B4CF-FA4C2EAF9097Q36075452-63352446-0CB5-4DC5-BC28-2F2FFA0F31EFQ36816005-FA5CC43F-D32D-45C9-83B6-494A2B1AF373Q37009138-03085A84-C0C8-4C1B-AA69-6A1C6010070EQ37544974-32679D49-239E-41B7-A77B-B5F704C2651AQ37546655-C15B57CC-4C65-42A6-92FC-254EC30DDF6EQ37721755-6F696F0B-9688-4556-9381-AF74E103C87AQ38842229-1AD68796-A455-4112-A2D7-407172F73C30Q44127212-B3F10F24-3B93-436B-9844-EEDDF6EF448AQ47132900-C6CEC63D-08D9-4AD4-A02A-EECE3999C1F8Q58719957-BDA52A5D-427F-4D65-B016-CCF63E12B81A
P2860
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@ast
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@en
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@nl
type
label
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@ast
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@en
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@nl
prefLabel
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@ast
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@en
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.
@nl
P1476
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
@en
P2093
M Woodhead
P304
P356
10.1183/09031936.02.00702002
P577
2002-07-01T00:00:00Z